Mark Cuban Enters Custom Rare Disease Manufacturing at Dallas Factory

By Jason Mast · STAT News · 2026-10-21

STAT News reports that Cost Plus Drugs is pivoting its manufacturing strategy to include highly personalized treatments for rare genetic conditions. Mark Cuban is dedicating a portion of his new Texas facility to producing DNA-like molecules designed for individual patients, movi

STAT News reports that Cost Plus Drugs is pivoting its manufacturing strategy to include highly personalized treatments for rare genetic conditions. Mark Cuban is dedicating a portion of his new Texas facility to producing DNA-like molecules designed for individual patients, movi